Pipeline

Pipeline

Products
Pipeline
Pipeline

Information

With approved biosimilars already on the market and a robust pipeline of differentiated assets,Polpharma Biologics is well-positioned to shape the future of biosimilars. Strategic collaborationswith industry leaders demonstrate the company's ability to co-create value and deliver at scale.
Polpharma BiologicsPolpharma Biologics is a Swiss-headquartered biosimilar company focused on accelerating access to biologic medicines through science, agility, and smart partnerships. With a lean, flexible model and a strong legacy, it enables cost-efficient development and global scalability. With multiple approved biosimilars and a robust pipeline—including first-to-launch assets—Polpharma Biologics partners globally to deliver affordable, high-quality biologics to patients worldwide.

Log in

See all the content and easy-to-use features by logging in or registering!